Dr. Mailliard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Emile At 42nd St
Omaha, NE 68198Phone+1 402-559-4015- Is this information wrong?
Summary
- Dr. Mark Mailliard is a gastroenterologist in Omaha, NE and is affiliated with multiple hospitals in the area, including Nebraska Medicine - Nebraska Medical Center and Veterans Affairs Nebraska-Western Iowa Health Care System. He received his medical degree from University of Nebraska College of Medicine. He specializes in general gastroenterology and hepatology, biliary tract disease, and gi endoscopy.
Education & Training
University of FloridaFellowship, Gastroenterology, 1984 - 1987
University of Nebraska Medical Center College of MedicineFellowship, Gastroenterology, 1983 - 1984- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1981 - 1983
University of Nebraska College of MedicineClass of 1980
Certifications & Licensure
NE State Medical License 1982 - 2024
FL State Medical License 1984 - 2022
IA State Medical License 2011 - 2022
SD State Medical License Active through 2021
TX State Medical License 1996 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients Start of enrollment: 2008 Apr 01
- Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C Start of enrollment: 2009 Apr 15
- Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers Start of enrollment: 2009 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.Patrick A Twohig, Kyle Scholten, Makayla Schissel, Kevin Brittan, Jason Barbaretta, Kaeli Samson, Lynette Smith, Mark Mailliard, Thoetchai Bee Peeraphatdit> ;Digestive Diseases and Sciences. 2023 Dec 1
- 16 citationsCost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States.Moosa Tatar, Susana Keeshin, Mark E. Mailliard, Fernando A. Wilson> ;JAMA Network Open. 2020 Sep 1
- 41 citationsEffectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J. Feld, Raoel Maan, Stefan Zeuzem, Alexander Kuo, David R. Nelson, Adrian M. Di Bisceglie, Michael P. Manns, Kenneth E. Sherman, Lynn M. Frazier, Richard K. St...> ;Clinical Infectious Diseases. 2016 Sep 15
- Join now to see all
Press Mentions
UNMC for the RecordNovember 30th, 2018
Grant Support
- Amino Acid Control Of Plasma Membrane Protein SynthesisNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1993
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
Nebraska Medicine - Nebraska Medical CenterOmaha, Nebraska
Omaha VA Medical CenterOmaha, Nebraska
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
